Trial intelligence / Profile preview

Lyophilized live attenuated varicella vaccine in healthy children

CTR20190323Phase 3Completed

Sponsor
Beijing Minhai Biological
Start
Jun 2019
Modality
Prophylactic Vaccines → Vaccines & Immunotherapeutics, Live Biotherapeutic Products → Microbiome Therapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Countries
1
01

Overview

A Phase 3 trial of varicella virus vaccine live in chickenpox, sponsored by Beijing Minhai Biological. Started Jun 2019; status: completed.

02

Drugs

varicella virus vaccine live
03

Conditions

chickenpox

Beyond the preview

Go deeper on CTR20190323.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20190323.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call